• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌和肺鳞状细胞癌基因表达的系统分析及[具体病例]的病例研究

Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of and .

作者信息

Cai Ling, Luo Danni, Yao Bo, Yang Donghan M, Lin ShinYi, Girard Luc, DeBerardinis Ralph J, Minna John D, Xie Yang, Xiao Guanghua

机构信息

Quantitative Biomedical Research Center, Department of Population and Data Sciences, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

Howard Hughes Medical Institute and Children's Medical Center Research Institute, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

出版信息

Cancers (Basel). 2019 Jun 25;11(6):886. doi: 10.3390/cancers11060886.

DOI:10.3390/cancers11060886
PMID:31242643
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6627508/
Abstract

INTRODUCTION

In our previous study, we constructed a Lung Cancer Explorer (LCE) database housing lung cancer-specific expression data and clinical data from over 6700 patients in 56 studies.

METHODS

Using this dataset of the largest collection of lung cancer gene expression along with our meta-analysis method, we systematically interrogated the association between gene expression and overall survival as well as the expression difference between tumor and normal (adjacent non-malignant tissue) samples in lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SQCC). A case study for and was performed as a demonstration for hypothesis testing with our database.

RESULTS

We showed that the reproducibility of results across studies varied by histological subtype and analysis type. Genes and pathways unique or common to the two histological subtypes were identified and the results were integrated into LCE to facilitate user exploration. In our case study, we verified the findings from a previous study on and in non-small cell lung cancer.

CONCLUSIONS

This study used gene expression data from a large cohort of patients to explore the molecular differences between lung ADC and SQCC.

摘要

引言

在我们之前的研究中,我们构建了一个肺癌探索者(LCE)数据库,其中包含来自56项研究的6700多名患者的肺癌特异性表达数据和临床数据。

方法

利用这个最大规模肺癌基因表达数据集以及我们的荟萃分析方法,我们系统地研究了基因表达与总生存期之间的关联,以及肺腺癌(ADC)和肺鳞状细胞癌(SQCC)中肿瘤与正常(相邻非恶性组织)样本之间的表达差异。对[具体内容]进行了案例研究,作为使用我们数据库进行假设检验的示范。

结果

我们表明,不同组织学亚型和分析类型的研究结果可重复性存在差异。确定了两种组织学亚型特有的或共有的基因和通路,并将结果整合到LCE中以方便用户探索。在我们的案例研究中,我们验证了之前一项关于非小细胞肺癌中[具体内容]的研究结果。

结论

本研究使用大量患者的基因表达数据来探索肺ADC和SQCC之间的分子差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/2f3c75d2c95b/cancers-11-00886-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/35f09e2df8fd/cancers-11-00886-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/4f94b59a4d29/cancers-11-00886-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/c0f7d41a5f70/cancers-11-00886-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/84de96f2df2b/cancers-11-00886-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/d41172d963c0/cancers-11-00886-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/672176cd9282/cancers-11-00886-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/2f3c75d2c95b/cancers-11-00886-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/35f09e2df8fd/cancers-11-00886-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/4f94b59a4d29/cancers-11-00886-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/c0f7d41a5f70/cancers-11-00886-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/84de96f2df2b/cancers-11-00886-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/d41172d963c0/cancers-11-00886-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/672176cd9282/cancers-11-00886-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4be0/6627508/2f3c75d2c95b/cancers-11-00886-g007.jpg

相似文献

1
Systematic Analysis of Gene Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma with a Case Study of and .肺腺癌和肺鳞状细胞癌基因表达的系统分析及[具体病例]的病例研究
Cancers (Basel). 2019 Jun 25;11(6):886. doi: 10.3390/cancers11060886.
2
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.FAM83A和FAM83B作为非小细胞肺癌的预后生物标志物及潜在的新治疗靶点
Cancers (Basel). 2019 May 11;11(5):652. doi: 10.3390/cancers11050652.
3
Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor.序列相似性家族83成员B是肺腺癌预后不良的预测指标及表达野生型表皮生长因子受体的肺腺癌潜在治疗靶点。
Oncol Lett. 2018 Feb;15(2):1549-1558. doi: 10.3892/ol.2017.7517. Epub 2017 Dec 5.
4
FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.FAM83B 是肺鳞癌诊断和预后的新型生物标志物。
Int J Oncol. 2015 Mar;46(3):999-1006. doi: 10.3892/ijo.2015.2817. Epub 2015 Jan 7.
5
Elevated FAM83A expression predicts poorer clincal outcome in lung adenocarcinoma.FAM83A 表达水平升高预示肺腺癌患者临床预后不良。
Cancer Biomark. 2019;26(3):367-373. doi: 10.3233/CBM-190520.
6
Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma.是肺腺癌的预后标志物和潜在致癌基因。
DNA Cell Biol. 2020 May;39(5):890-899. doi: 10.1089/dna.2019.4970. Epub 2020 Apr 13.
7
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma.PD-L1表达及PD-L1基因多态性与肺腺癌和肺鳞癌预后不良的相关性
Hum Pathol. 2017 Oct;68:103-111. doi: 10.1016/j.humpath.2017.08.016. Epub 2017 Aug 26.
8
Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis.通过荟萃分析确定CDKN3基因表达作为肺腺癌的预后生物标志物
Cancer Inform. 2015 May 24;14(Suppl 2):183-91. doi: 10.4137/CIN.S17287. eCollection 2015.
9
Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.P63和CK5/6在肺细针穿刺标本中鉴别鳞状细胞癌与腺癌的价值。
Diagn Cytopathol. 2009 Mar;37(3):178-83. doi: 10.1002/dc.20975.
10
Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma.核纤层蛋白在肺腺癌和肺鳞状细胞癌中的表达及作用
Int J Oncol. 2008 Dec;33(6):1177-85.

引用本文的文献

1
Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma.综合分析显示,关键的顺铂耐药调节因子E2F7促成了肺腺癌的肿瘤进展和转移。
Cancer Cell Int. 2024 May 17;24(1):173. doi: 10.1186/s12935-024-03366-6.
2
Comprehensive analysis of INTS family related to expression, prognosis, diagnosis and immune features in hepatocellular carcinoma.肝细胞癌中与INTS家族的表达、预后、诊断及免疫特征相关的综合分析
Heliyon. 2024 Apr 24;10(9):e30244. doi: 10.1016/j.heliyon.2024.e30244. eCollection 2024 May 15.
3
FAM83B promotes cell proliferation via regulating the expression of CDK4/CDK6/CCND1 complex in laryngeal squamous cell carcinoma.

本文引用的文献

1
FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.FAM83A和FAM83B作为非小细胞肺癌的预后生物标志物及潜在的新治疗靶点
Cancers (Basel). 2019 May 11;11(5):652. doi: 10.3390/cancers11050652.
2
LCE: an open web portal to explore gene expression and clinical associations in lung cancer.LCE:一个开放的网络门户,用于探索肺癌中的基因表达和临床关联。
Oncogene. 2019 Apr;38(14):2551-2564. doi: 10.1038/s41388-018-0588-2. Epub 2018 Dec 7.
3
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
FAM83B通过调节喉鳞状细胞癌中CDK4/CDK6/CCND1复合物的表达促进细胞增殖。
Heliyon. 2024 Apr 23;10(9):e29933. doi: 10.1016/j.heliyon.2024.e29933. eCollection 2024 May 15.
4
High-resolution transcriptomics analysis of CXCL13 EPSTI1 CDK1 cells with a specific focus on lung adenocarcinoma.对CXCL13、EPSTI1、CDK1细胞进行高分辨率转录组学分析,特别关注肺腺癌。
J Thorac Dis. 2024 Jan 30;16(1):201-214. doi: 10.21037/jtd-23-1164. Epub 2024 Jan 16.
5
Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.基于人群的高维分析确定了针对肺鳞癌的癌症疫苗的多种内在特征。
Med Oncol. 2024 Jan 3;41(2):42. doi: 10.1007/s12032-023-02214-3.
6
Involvement of FAM83 Family Proteins in the Development of Solid Tumors: An Update Review.FAM83家族蛋白在实体瘤发生发展中的作用:最新综述
J Cancer. 2023 Jun 26;14(10):1888-1903. doi: 10.7150/jca.83420. eCollection 2023.
7
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma.跨膜丝氨酸蛋白酶 2 是肺腺癌的一个预后因素。
Int J Oncol. 2022 Apr;60(4). doi: 10.3892/ijo.2022.5329. Epub 2022 Feb 25.
8
Identification of Tissue-Specific Gene Clusters Induced by DNA Demethylation in Lung Adenocarcinoma: More Than Germline Genes.肺腺癌中DNA去甲基化诱导的组织特异性基因簇的鉴定:不止种系基因
Cancers (Basel). 2022 Feb 16;14(4):1007. doi: 10.3390/cancers14041007.
9
Identification of prognostically relevant gene signatures in lung squamous cell carcinoma by Lung Cancer Explorer.通过肺癌探索者鉴定肺鳞状细胞癌中与预后相关的基因特征。
Transl Cancer Res. 2021 May;10(5):2009-2022. doi: 10.21037/tcr-21-222.
10
Lung Cancer Computational Biology and Resources.肺癌计算生物学和资源。
Cold Spring Harb Perspect Med. 2022 Feb 1;12(2):a038273. doi: 10.1101/cshperspect.a038273.
主要组织相容性复合体 II 类和程序性死亡配体 1 表达预测经典霍奇金淋巴瘤接受程序性死亡 1 阻断后的结局。
J Clin Oncol. 2018 Apr 1;36(10):942-950. doi: 10.1200/JCO.2017.77.3994. Epub 2018 Feb 2.
4
The biology and management of non-small cell lung cancer.非小细胞肺癌的生物学特性与治疗管理。
Nature. 2018 Jan 24;553(7689):446-454. doi: 10.1038/nature25183.
5
MHC class II expression in lung cancer.肺癌中的 MHC Ⅱ类分子表达。
Lung Cancer. 2017 Oct;112:75-80. doi: 10.1016/j.lungcan.2017.07.030. Epub 2017 Jul 29.
6
Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries.腺癌和鳞状细胞癌的比较转录组揭示了跨越经典解剖学界限的分子相似性。
PLoS Genet. 2017 Aug 7;13(8):e1006938. doi: 10.1371/journal.pgen.1006938. eCollection 2017 Aug.
7
Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape.肺腺癌和肺鳞癌基因表达亚型在肿瘤免疫格局上表现出显著差异。
J Thorac Oncol. 2017 Jun;12(6):943-953. doi: 10.1016/j.jtho.2017.03.010. Epub 2017 Mar 21.
8
FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach.FAM83家族致癌基因广泛参与人类癌症:一种整合多组学方法。
Mol Oncol. 2017 Feb;11(2):167-179. doi: 10.1002/1878-0261.12016. Epub 2017 Jan 9.
9
Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers.肺癌的肺腺癌(LUAD)和肺鳞癌(LUSC)亚型之间免疫反应相关基因的差异调控。
Oncotarget. 2017 Jan 3;8(1):133-144. doi: 10.18632/oncotarget.13346.
10
FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance.FAM83蛋白:促进新的相互作用以驱动致癌信号传导和治疗抗性。
Oncotarget. 2016 Aug 9;7(32):52597-52612. doi: 10.18632/oncotarget.9544.